Parsol 1789 safety/effectiveness with some Category I sunscreens established -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
PARSOL 1789 SAFETY/EFFECTIVENESS WITH CATEGORY I SUNSCREENS ESTABLISHED, FDA concluded in a May 9 letter to King & Spalding attorney Edward Basile. In response to the March 2, 1993 citizen petition filed by Basile on behalf on Givaudan-Roure, FDA said it would allow use of UVA blocker Parsol 1789 (avobenzone) 2%-3% in combination with some Category I sunscreen ingredients. The petition is now being handled by Givaudan-Roure sister company Hoffmann-La Roche.